LONDON (Reuters) - There is a lot of reassuring evidence that suggests there is no increased risk of blood clots from AstraZeneca’s COVID-19 vaccine, England’s deputy chief medical officer said, adding he expected the European Medicines Agency to agree. “Behind the scenes, there is a lot of work going on to look at whether there is a signal in relation to what we call venous thrombo-embolic events - clots,” Jonathan Van-Tam said at a news conference on Wednesday. “And there’s a lot of evidence emerging now that is reassuring that there is no overall excess signal or increased risk. And I expect, without prejudice to their absolute findings, those to be the final conclusions of the EMA and (Britain’s) MHRA in due course.”